Canine mast cell tumours: decision-making and treatment
Mast cell tumours (MCTs) are common tumours in dogs. They mainly affect the skin, although they can affect other tissues and organs. In recent years, there have been significant advances in predicting skin MCT behaviour and treatment, including the licensing of two tyrosine kinase inhibitors for the...
Saved in:
Published in: | In practice (London 1979) Vol. 37; no. 7; pp. 315 - 332 |
---|---|
Main Authors: | , , , |
Format: | Journal Article |
Language: | English |
Published: |
London
BMJ Publishing Group Limited
01-07-2015
Blackwell Publishing Ltd |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Mast cell tumours (MCTs) are common tumours in dogs. They mainly affect the skin, although they can affect other tissues and organs. In recent years, there have been significant advances in predicting skin MCT behaviour and treatment, including the licensing of two tyrosine kinase inhibitors for the treatment of this condition. This article focuses on skin (cutaneous and subcutaneous) MCTs. It summarises current understanding of MCT behaviour, prognosis and treatment, with a particular focus on treatment decision-making. |
---|---|
ISSN: | 0263-841X 2042-7689 |
DOI: | 10.1136/inp.h3440 |